PET Imaging Agents (FES, FFNP, and FDHT) for Estrogen, Androgen, and Progesterone Receptors to Improve Management of Breast and Prostate Cancers by Functional Imaging

by John A. Katzenellenbogen
Published 2020-07-01

Designer antiandrogens join the race against drug resistance

by Jatinder S Josan, John A Katzenellenbogen
Published 2013-04-01

Non-genomic estrogen regulation of ion transport and airway surface liquid dynamics in cystic fibrosis bronchial epithelium.

by Vinciane Saint-Criq, Sung Hoon Kim, John A Katzenellenbogen, Brian J Harvey
Published 2013-01-01

Association of PET-based estradiol-challenge test for breast cancer progesterone receptors with response to endocrine therapy

by Farrokh Dehdashti, Ningying Wu, Cynthia X. Ma, Michael J. Naughton, John A. Katzenellenbogen, Barry A. Siegel
Published 2021-02-01

Suppression of Tumor Growth, Metastasis, and Signaling Pathways by Reducing FOXM1 Activity in Triple Negative Breast Cancer

by Parama Dey, Alexander Wang, Yvonne Ziegler, Sung Hoon Kim, Dorraya El-Ashry, John A. Katzenellenbogen, Benita S. Katzenellenbogen
Published 2020-09-01

Pocket similarity identifies selective estrogen receptor modulators as microtubule modulators at the taxane site

by Yu-Chen Lo, Olga Cormier, Tianyun Liu, Kendall W. Nettles, John A. Katzenellenbogen, Tim Stearns, Russ B. Altman
Published 2019-03-01

Radiosynthesis and Evaluation of Talazoparib and Its Derivatives as PARP-1-Targeting Agents

by Dong Zhou, Huaping Chen, Cedric Mpoy, Sadia Afrin, Buck E. Rogers, Joel R. Garbow, John A. Katzenellenbogen, Jinbin Xu
Published 2021-05-01

Salicylaldoximes and anthranylaldoximes as alternatives to phenol-based estrogen receptor ligands

by Filippo Minutolo, Simone Bertini, Adriano Martinelli, Gabriella Ortore, Giorgio Placanica, Giovanni Prota, Simona Rapposelli, Tiziano Tuccinardi, Shubin Sheng, Kathryn E. Carlson, Benita S. Katzenellenbogen, John A. Katzenellenbogen, Marco Macchia
Published 2006-06-01

Diffusion tensor imaging identifies aspects of therapeutic estrogen receptor β ligand-induced remyelination in a mouse model of multiple sclerosis

by Kelley C. Atkinson, Jeong Bin Lee, Jonathan P.C. Hasselmann, Sung Hoon Kim, Alyson Drew, Joselyn Soto, John A. Katzenellenbogen, Neil G. Harris, Andre Obenaus, Seema K. Tiwari-Woodruff
Published 2019-10-01

Estrogen receptor alpha somatic mutations Y537S and D538G confer breast cancer endocrine resistance by stabilizing the activating function-2 binding conformation

by Sean W Fanning, Christopher G Mayne, Venkatasubramanian Dharmarajan, Kathryn E Carlson, Teresa A Martin, Scott J Novick, Weiyi Toy, Bradley Green, Srinivas Panchamukhi, Benita S Katzenellenbogen, Emad Tajkhorshid, Patrick R Griffin, Yang Shen, Sarat Chandarlapaty, John A Katzenellenbogen, Geoffrey L Greene
Published 2016-02-01

Resveratrol modulates the inflammatory response via an estrogen receptor-signal integration network

by Jerome C Nwachukwu, Sathish Srinivasan, Nelson E Bruno, Alexander A Parent, Travis S Hughes, Julie A Pollock, Olsi Gjyshi, Valerie Cavett, Jason Nowak, Ruben D Garcia-Ordonez, René Houtman, Patrick R Griffin, Douglas J Kojetin, John A Katzenellenbogen, Michael D Conkright, Kendall W Nettles
Published 2014-04-01

The SERM/SERD bazedoxifene disrupts ESR1 helix 12 to overcome acquired hormone resistance in breast cancer cells

by Sean W Fanning, Rinath Jeselsohn, Venkatasubramanian Dharmarajan, Christopher G Mayne, Mostafa Karimi, Gilles Buchwalter, René Houtman, Weiyi Toy, Colin E Fowler, Ross Han, Muriel Lainé, Kathryn E Carlson, Teresa A Martin, Jason Nowak, Jerome C Nwachukwu, David J Hosfield, Sarat Chandarlapaty, Emad Tajkhorshid, Kendall W Nettles, Patrick R Griffin, Yang Shen, John A Katzenellenbogen, Myles Brown, Geoffrey L Greene
Published 2018-11-01